Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TG6-10-1
Cat. No.:
0225LY-1124
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
TG6-10-1 is identified as an antagonist of the EP2 receptor.
Synonym:
1415716-58-3; (E)-N-(2-(2-(Trifluoromethyl)-1H-indol-1-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)acrylamide; (E)-N-[2-[2-(trifluoromethyl)indol-1-yl]ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide; (2E)-N-{2-[2-(trifluoromethyl)-1H-indol-1-yl]ethyl}-3-(3,4,5-trimethoxyphenyl)prop-2-enamide
CAS No.:
1415716-58-3
Compound CID:
71499384
Formula:
C23H23F3N2O4
Formula Weight:
448.43
Specification
Relative Density:
1.24 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
TG6-10-1 can be used in neuroscience to investigate the selective antagonism of the EP2 prostaglandin receptor.
Library Information
Target:
5-HT receptor; Prostaglandin receptor
Receptor:
5-HT2B; Prostaglandin receptor
Pathways:
Immunology/Inflammation; GPCR/G protein signaling; Neuronal signaling
Plate Number:
AOCL-15
Plate Location:
d10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 133.8 mM
